The Canadian National Vaccine Safety Network : surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada

Bettinger, Julie A.; Sadarangani, Manish; De Serres, Gaston; Valiquette, Louis; Vanderkooi, Otto G.; Kellner, James D.; Muller, Matthew P.; Top, Karina A.; Isenor, Jennifer E.; McGeer, Allison; Marty, Kimberly; Canadian Immunization Research Network

The Canadian National Vaccine Safety Network : surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada

Simple item page

Full item details

dc.contributor.author: Bettinger, Julie A.; Sadarangani, Manish; De Serres, Gaston; Valiquette, Louis; Vanderkooi, Otto G.; Kellner, James D.; Muller, Matthew P.; Top, Karina A.; Isenor, Jennifer E.; McGeer, Allison; Marty, Kimberly; Canadian Immunization Research Network
dc.date.accessioned: 2025-01-31T19:53:59Z
dc.date.available: 2025-01-31T19:53:59Z
dc.date.issued: 2022-01-20
dc.description.abstract - en: Introduction COVID-19 vaccines require enhanced safety monitoring after emergency approval. The Canadian National Vaccine Safety Network monitors the safety of COVID-19 vaccines and provides enhanced monitoring for healthy, auto-immune, immunocompromised, pregnant and breastfeeding populations and allows for the detection of safety signals. Methods and analysis Online participant reporting of health events in vaccinated and unvaccinated individuals 12 years of age and older is captured in three surveys: 1 week after dose 1, 1 week after dose 2 and 7 months after dose 1. Medically attended events are followed up by telephone. The number, percentage, rate per 10 000 and incident rate ratios with 95% CIs are calculated by health event, vaccine type, sex and in 10-year age groups. Ethics and dissemination Each study site has Research Ethics Board approvals for the project (UBC Children’s & Women’s, CIUSSS de l'Estrie—CHUS, Health PEI, Conjoint Health Research Ethics Board, University of Calgary and Alberta Health Services, IWK Health, Unity Health Toronto and CHU de Québec-Université Laval Research Ethics Boards). Individuals are invited to participate in this active surveillance and electronic consent is given before proceeding to each survey. Weekly reports are shared with public health and posted on the study website. At least one peer-reviewed manuscript is produced.
dc.description.sponsorship: This work was supported by the COVID-19 Vaccine Readiness funding from the Canadian Institutes of Health Research and the Public Health Agency of Canada CANVAS grant number CVV-450980. This project was supported by funding from the Public Health Agency of Canada, through the Vaccine Surveillance Reference group and the COVID-19 Immunity Task Force. MS is supported via salary awards from the BC Children’s Hospital Foundation, the Canadian Child Health Clinician Scientist Programme and the Michael Smith Foundation for Health Research.
dc.identifier.doi: https://doi.org/10.1136/bmjopen-2021-051254
dc.identifier.issn: 2044-6055
dc.identifier.pubmedID: 35058258
dc.identifier.uri: https://open-science.canada.ca/handle/123456789/3385
dc.language.iso: en
dc.publisher - en: BMJ
dc.rights - en: Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
dc.rights - fr: Creative Commons Attribution-Pas d’Utilisation Commerciale 4.0 International (CC BY-NC 4.0)
dc.rights.openaccesslevel - en: Gold
dc.rights.openaccesslevel - fr: Or
dc.rights.uri - en: https://creativecommons.org/licenses/by-nc/4.0/
dc.rights.uri - fr: https://creativecommons.org/licenses/by-nc/4.0/deed.fr
dc.subject - en: Health; Coronavirus diseases; Immunization; Epidemiology
dc.subject - fr: Santé; Maladie à coronavirus; Immunisation; Épidémiologie
dc.subject.en - en: Health; Coronavirus diseases; Immunization; Epidemiology
dc.subject.fr - fr: Santé; Maladie à coronavirus; Immunisation; Épidémiologie
dc.title - en: The Canadian National Vaccine Safety Network : surveillance of adverse events following immunisation among individuals immunised with the COVID-19 vaccine, a cohort study in Canada
dc.type - en: Article
dc.type - fr: Article
local.acceptedmanuscript.articlenum: e051254
local.article.journaltitle - en: BMJ Open
local.article.journalvolume: 12
local.pagination: 1-6
local.peerreview - en: Yes
local.peerreview - fr: Oui